AU Stock MarketDetailed Quotes
ILAO Island Pharmaceuticals Ltd
- 0.105
- 0.0000.00%
20min DelayClosing Auction Session Nov 18 16:00 AET
16.37MMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.105Pre Close0.00Turnover0.11552wk High0.00%Turnover Ratio155.86MShares0.01052wk Low--EPS TTM4.91MFloat Cap0.115Historical High0.00P/E (Static)46.78MShs Float0.010Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Island Pharmaceuticals Ltd Company
Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its drug candidate ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases. The company carries out its research and development activities principally in the geographic regions of Australia and the United States of America.
Company Profile
SymbolILAO
Company NameIsland Pharmaceuticals Ltd
Founded2020
MarketASX
Fiscal Year Ends06-30
Addressc/- Bio101 Financial Advisory Pty Ltd 697 Burke Road, Suite 201
CityMelbourne
CountryAustralia
Zip Code3124
Phone+61 370367675
Share RegistryAUTOMIC REGISTRY SERVICES
Level 1, 45 Clarence Street, SYDNEY, NSW, AUSTRALIA, 2000
13 25 83
Company Executives
- Name
- Position
- Salary
- David Foster
- Chief Executive Officer,Executive Director
- --
- Paul MacLeman
- Executive Chairman,Executive Director
- --
- Anna Lavelle
- Non-Executive Director
- --
- Albert Hansen
- Non-Executive Director
- --
- David Lionel Brookes
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data